INTROGEN THERAPEUTICS INC
INTROGEN THERAPEUTICS INC (INGN) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 1009 transactions totaling $216.5M, demonstrating a bearish sentiment with -$216.3M in net insider flow. The most recent transaction on Dec 1, 2025 involved a transaction of 13,817 shares valued at $96.0K.
INGN Insider Activity Summary
Who Is Buying INGN Stock?
No significant insider buying has been recorded for INGN in the recent period.
Who Is Selling INGN Stock?
No significant insider selling has been recorded for INGN in the recent period.
Is INTROGEN THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INGN is bearish with an Insider Alignment Score of 0/100 and a net flow of -$216.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
INGN Frequently Asked Questions
Understanding INGN Insider Activity
Insider trading at INTROGEN THERAPEUTICS INC (INGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading INGN stock, having executed 1009 transactions in the past 90 days. The most active insider is Holdings A/s Novo (Executive), who has made 2 transactions totaling $77.7M.
Related Tools
Track INTROGEN THERAPEUTICS INC Insider Activity
Get notified when executives and directors at INGN file new Form 4 transactions